Could a zappy headband fix insomnia in MS patients?

NCT ID NCT07558616

First seen May 05, 2026 · Last updated Jun 24, 2026 · Updated 6 times

Summary

This study tests whether a device that sends mild electrical currents to the brain (hi-tACS) can improve sleep in people with neuroimmune diseases like multiple sclerosis or neuromyelitis optica who also have insomnia. Eighty participants will receive 20 sessions of the stimulation over four weeks. Researchers will track sleep quality and insomnia severity for up to two months after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China

    RECRUITING

    Beijing, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

high-intensity transcranial alternating current stimulation (hi-tACS) device

What this could lead to

If it works, this could offer a non-drug option to help people with neuroimmune diseases sleep better.

What could go wrong

This is an early study with only 80 participants, and it's not yet known if the effects last or if the device works better than a placebo.

Conditions

The condition(s) this trial relates to.

multiple sclerosis neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.